首页|生物传感器分析技术及其在阿尔茨海默病药物研发中的研究进展

生物传感器分析技术及其在阿尔茨海默病药物研发中的研究进展

扫码查看
生物传感器分析技术是一类可将生物反应转换为光电信号的高特异性技术,在阿尔茨海默病(Alzheimer's disease,AD)药物研发中,针对AD不同假说、不同靶点,该技术在确证靶标、筛选活性化合物方面发挥了重要作用.该文简述AD发病机制与治疗药物现况,重点介绍了 AD药物研发中常用的表面等离子共振技术(surface plasmon resonance,SPR)、生物膜干涉技术(biolayer interferometry,BLI)与荧光分析技术这三类生物传感器分析技术,阐释其基本原理及其应用进展,并总结各自的优势与局限.
Biosensor analysis technology and its research progress in drug development of Alzheimer's disease
Biosensor analysis technology is a kind of technology with high specificity that can convert biological reactions into optical and electrical signals.In the development of drugs for Alzheimer's disease(AD),according to different disease hypotheses and targets,this technology plays an important role in confirming targets and screening active compounds.This paper briefly describes the pathogenesis of AD and the current situation of therapeutic drugs,introduces three biosensor analysis techniques commonly used in the discovery of AD drugs,such as surface plasmon resonance(SPR),biolayer interferometry(BLI)and fluorescence analysis technology,explains its basic principle and application progress,and summarizes their advantages and limitations respectively.

Alzheimer's diseasebiosensorsurface plasmon resonancebiolayer interferometryfluorescence analysis technologydrug screening

沈淑琦、方家豪、王辉、晁亮、游飘雪、洪战英

展开 >

海军军医大学药学院,上海市药物(中药)代谢产物重点实验室,上海 200433

福建中医药大学药学院,福建福州 350122

阿尔茨海默病 生物传感器 表面等离子共振技术 生物膜干涉技术 荧光分析技术 药物筛选

国家自然科学基金

82173777

2024

药学学报
中国药学会 中国医学科学院药物研究所

药学学报

CSTPCD北大核心
影响因子:1.274
ISSN:0513-4870
年,卷(期):2024.59(3)
  • 112